Correlation Between Scopus Biopharma and Adhera Therapeutics
Can any of the company-specific risk be diversified away by investing in both Scopus Biopharma and Adhera Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scopus Biopharma and Adhera Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Scopus Biopharma and Adhera Therapeutics, you can compare the effects of market volatilities on Scopus Biopharma and Adhera Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scopus Biopharma with a short position of Adhera Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scopus Biopharma and Adhera Therapeutics.
Diversification Opportunities for Scopus Biopharma and Adhera Therapeutics
0.3 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Scopus and Adhera is 0.3. Overlapping area represents the amount of risk that can be diversified away by holding Scopus Biopharma and Adhera Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Adhera Therapeutics and Scopus Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scopus Biopharma are associated (or correlated) with Adhera Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Adhera Therapeutics has no effect on the direction of Scopus Biopharma i.e., Scopus Biopharma and Adhera Therapeutics go up and down completely randomly.
Pair Corralation between Scopus Biopharma and Adhera Therapeutics
If you would invest 72.00 in Adhera Therapeutics on August 27, 2024 and sell it today you would earn a total of 0.00 from holding Adhera Therapeutics or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Scopus Biopharma vs. Adhera Therapeutics
Performance |
| Timeline |
| Scopus Biopharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Adhera Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Scopus Biopharma and Adhera Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Scopus Biopharma and Adhera Therapeutics
The main advantage of trading using opposite Scopus Biopharma and Adhera Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scopus Biopharma position performs unexpectedly, Adhera Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adhera Therapeutics will offset losses from the drop in Adhera Therapeutics' long position.| Scopus Biopharma vs. Scpharmaceuticals | Scopus Biopharma vs. DiaMedica Therapeutics | Scopus Biopharma vs. Monopar Therapeutics | Scopus Biopharma vs. Pasithea Therapeutics Corp |
| Adhera Therapeutics vs. Enveric Biosciences | Adhera Therapeutics vs. Akeso, Inc | Adhera Therapeutics vs. Avax Techs | Adhera Therapeutics vs. Ascletis Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |